Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
  • Supplementary Content
  • 10.3760/cma.j.cn101480-20250106-00006
Interpretation of the consensus of Chinese experts on gut microbiota and fecal microbiota transplantation in inflammatory bowel disease (2025 edition)
  • Mar 25, 2025
  • Chinese Journal of Inflammatory Bowel Diseases
  • Zhao, D + 2 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20241220-00143
Consensus of Chinese experts on gut microbiota and fecal microbiota transplantation in inflammatory bowel disease (2025 edition)
  • Mar 25, 2025
  • Chinese Journal of Inflammatory Bowel Diseases
  • Chen, Q + 1 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20240306-00033
Mechanism of action and application prospect of Akkermansia. muciniphila in inflammatory bowel disease
  • Jan 25, 2025
  • Chinese Journal of Inflammatory Bowel Diseases
  • Li, D + 1 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20230914-00019
Study of correlation between C1GalT1 protein and disease activity in ulcerative colitis
  • Nov 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Wang, Z + 5 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20230807-00006
Real world efficacy prediction analysis of infliximab in the treatment of Crohn's disease
  • Sep 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Lyu, C + 7 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20230906-00016
Significance of fungus-bacterium homeostasis in inflammatory bowel disease
  • Jul 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Chen, S + 6 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20230823-00014
A study of brain functional networks in patients with inflammatory bowel disease based on graph theory
  • Jul 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Wu, X + 7 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20230813-00008
Clinical manifestation and influence factor analysis of coronavirus disease 2019 infection in inflammatory bowel disease patients: a multicenter cross-sectional study
  • Jul 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Huang, T + 12 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20231104-00057
Influencing factors for secondary loss of response to vedolizumab in ulcerative colitis
  • May 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Xie, Y + 3 more

  • Supplementary Content
  • 10.3760/cma.j.cn101480-20240206-00019
Relationship between preoperative use of anti-tumor necrosis factor-α and postoperative infectious complications in Crohn′s disease
  • May 25, 2024
  • Chinese Journal of Inflammatory Bowel Diseases
  • Du, K + 6 more